Pulmicort and Hyperventilation - a phase IV clinical study of FDA data

Summary:

Hyperventilation is reported as a side effect among people who take Pulmicort (budesonide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Singulair, and have Adrenal insufficiency.

The phase IV clinical study analyzes which people have Hyperventilation when taking Pulmicort. It is created by eHealthMe based on reports of 34,552 people who have side effects when taking Pulmicort from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,979 Pulmicort users. Check the latest studies of Pulmicort.

What is Hyperventilation?

Hyperventilation is found to be associated with 783 drugs and 1,444 conditions by eHealthMe. Check the latest studies of Hyperventilation.

On Feb, 21, 2026

34,552 people reported to have side effects when taking Pulmicort.
Among them, 49 people (0.14%) have Hyperventilation.

Among these 49 people:

How long have people been on Pulmicort when they have Hyperventilation? *

What is the gender of people who have Hyperventilation when taking Pulmicort? *

female: 89.58 %
male: 10.42 %

What is the age of people who have Hyperventilation when taking Pulmicort? *

What are other drugs people take besides Pulmicort? *

What are other side effects people have besides Hyperventilation? *

Dyspnea (difficult or laboured breathing): 31 people, 63.27%
Pneumonia: 27 people, 55.10%
Wheezing (a high-pitched whistling sound made while you breath): 24 people, 48.98%
Infection: 24 people, 48.98%
Sleep Disorder: 22 people, 44.90%
Vaginal Infection: 22 people, 44.90%
Cough: 22 people, 44.90%
Weight Loss: 22 people, 44.90%
Pain In Extremity: 22 people, 44.90%
Rash Macular (small, flat red spots): 22 people, 44.90%

What are the existing conditions these people have? *

Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 18 people, 36.73%
Stress And Anxiety: 3 people, 6.12%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 2.04%
Gastric Ulcer (stomach ulcer): 1 person, 2.04%
Arrhythmias (irregular heartbeat): 1 person, 2.04%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.04%
Atypical Pneumonia (acute respiratory disease marked by high fever and coughing): 1 person, 2.04%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 2.04%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 2.04%
Fungal Nail Infection: 1 person, 2.04%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmicort:

Pulmicort (34,979 reports)

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperventilation:

Hyperventilation (783 drugs)

Browse all the conditions that are associated with Hyperventilation:

Hyperventilation (1,444 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Pulmicort) and Pulmicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.